AstraZeneca on Tuesday released full results from two successful late-stage trials on its experimental drug for chronic obstructive pulmonary disease, boosting hopes that it could generate multibillion-dollar sales for the company. The biologic medicine, tozorakimab, is under priority review by the Food and Drug Administration, with U.S. approval expected in the first quarter of 2027….
U.S. President Donald Trump delivers remarks on his administration’s healthcare policies, in the Oval Office at the White House in Washington, D.C., U.S., Aug. 31, 2026. Evelyn Hockstein | Reuters President Donald Trump on Monday said he struck new drug pricing deals with nine drugmakers to voluntarily sell their medications for less, building on his…
Gilead Bixlenvo drug Courtesy: Gilead The Food and Drug Administration approved a once-daily HIV pill from Gilead that could help simplify care for some patients, the company announced Thursday. The drug, marketed as Bixlenvo, is aimed at patients whose virus is already under control but who remain on complicated treatment regimens. It could also appeal…
A Medical Assistant gives a measles, mumps and rubella, vaccination to a young person at the pediatric office of Dr. Gary M. Kramer on Aug. 13, 2026, in Coral Gables, Florida. Joe Raedle | Getty Images Record measles cases and rising childhood vaccine exemptions in the U.S. have fueled concerns that Americans are increasingly turning…
US Secretary of Health and Human Services Robert F. Kennedy Jr. (R) looks on as President Donald Trump speaks before signing an executive order calling for more research and flexibility on vaccines, in the Oval Office of the White House in Washington, DC, on August 10, 2026. Jim Watson | Afp | Getty Images President…
The Eli Lilly and Novo Nordisk logos. Mike Blake | Tom Little | Reuters The diverging paths of two GLP-1 drugmakers were on full display this week. Both Eli Lilly and Novo Nordisk beat second-quarter estimates and raised their full-year outlooks. But while investors cheered Lilly’s results, sending shares higher on Wednesday, they punished Novo…
Pfizer Inc. signage on the floor of the New York Stock Exchange (NYSE) in New York, US, on Wednesday, March 4, 2026. Michael Nagle | Bloomberg | Getty Images Pfizer on Tuesday reported second-quarter results that topped estimates and hiked the low end of its revenue outlook, citing an added $1.5 billion in sales from…
The exterior view of the entrance to Merck headquarters in Rahway, New Jersey, on Feb. 5, 2024. Spencer Platt | Getty Images Merck on Tuesday beat second-quarter estimates and hiked its revenue outlook, as a slate of new products showed strong growth. But the pharmaceutical giant cut its profit guidance due to a charge tied…
A customer shops for cilantro at a Walmart Supercenter on July 23, 2026, in Austin, Texas. Brandon Bell | Getty Images The nation’s largest multistate outbreak of cyclosporiasis linked to shredded iceberg lettuce has expanded to nine states, the Centers for Disease Control and Prevention said Friday. The four newly linked states — Illinois, Kansas,…
While many new VC firms are still struggling to raise new capital, Dimension Capital, founded in late 2022, is rapidly raising large sums of money. On Tuesday, the New York firm — which invests at the intersection of science and computing — announced an $800 million fund, 60% larger than its $500 million The second…
